Families involved in the Zofran (ondansetron) multidistrict litigation (“MDL”) alleged a 2016 label update for Zofran acknowledged for the first time that studies have shown an increased link between exposure to Zofran (ondansetron) and cardiovascular and cleft palate birth defects in babies born to women who took the drug while pregnant. However, the families contend...
Read more
Zofran (ondansetron) MDL Judge Denies GlaxoSmithKline’s Request for Dismissal as Premature
In the latest development of the Zofran (ondansetron) multi-district litigation, GlaxoSmithKline’s request for dismissal of all claims were denied by Judge F. Dennis Saylor IV, the Massachusetts district judge presiding over the litigation. About 200 cases with similar claims were consolidated into the multidistrict litigation, or “MDL,” for the purpose of streamlining...
First Zoloft Trial in MDL to Take Place March 2016
Over the past three years, hundreds of lawsuits have been filed against Pfizer, maker of Zoloft, surrounding accusations that the antidepressant caused birth defects when used during pregnancy. The cases were recently centralized in an MDL (multi-district litigation, or a mechanism courts use to coordinate cases alleging similar claims) in the Eastern District of...
Avelox, Levaquin Users Seek MDL Over Peripheral Neuropathy Side Effects
After at least 24 product liability lawsuits were filed in 16 different courts against makers of fluoroquinolone antibiotics (FLQs) Levaquin, Cipro, Avelox, and other similar drugs, plaintiffs are now seeking to consolidate their cases into one multi-district litigation, or “MDL,” which is a mechanism courts to centralize many similar cases to expedite future proceedings. The...
Read more
